Newsletter Archive

1. 07.29.21 -- Overcoming Patient Recruitment And Retention Challenges In Rare Disease Studies 7/29/2021

   07/29/21 Clinical Leader Newsletter

2. 07.28.21 -- No CMOs Or CROs: A Unique Approach To Cell Therapy Development 7/28/2021
   07/28/21 Clinical Leader Newsletter
3. 07.27.21 -- Patient Centricity When Implementing Decentralized Trials 7/27/2021

   07/27/21 Clinical Leader Newsletter

4. 07.26.21 -- The Right Precision Medicine Partner Is Essential For Trials And Patients 7/26/2021
   07/26/21 Clinical Leader Newsletter
5. 07.26.21 -- Strategies To Optimize Virtual And Decentralized Study Designs 7/26/2021
   07/26/21 Clinical Leader Newsletter
6. 07.21.21 -- How One Biotech Is Taking An Innovative Approach To Alzheimer's Disease 7/21/2021
   07/21/21 Clinical Leader Newsletter
7. 07.20.21 -- Minimizing Risk And Maximizing Success With Study Feasibility 7/20/2021

   07/20/21 Clinical Leader Newsletter

8. 07.19.21 -- Merck's Efforts To Increase Patient Diversity 7/19/2021
   07/19/21 Clinical Leader Newsletter
9. 07.19.21 -- Does Your Clinical Trial Design Satisfy Patient Needs? 7/19/2021

   07/19/21 Clinical Leader Newsletter

10. 07.15.21 -- Choose The Right FDA Program To Expedite Your Rare Oncology Trial 7/15/2021

    07/15/21 Clinical Leader Newsletter